- Citations, last 5 years
- 13.8k
- Works, last 5 years
- 2 014
- h-index
- 580
- Scientists listed
- 0
- Grants since 2016
- 630
Grants received
2020–2024 · research · R01
Molecular Mechanism of UV Protection in Cutaneous Melanoma
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2025 · grant · MRP
Targeting Acral Melanoma by Inducing TERT Degradation
Jessie Villanueva · The Wistar Institute · funded by Congressionally Directed Medical Research Programs
2020–2024 · research · R00
Modeling cancer evolution for prediction with neural networks: methods and applications
Noam Auslander · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
Regulation of neonatal inflammation by myeloid-derived suppressor cells
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2020–2022 · career development · K99
Targeting HSP70 in CARM1-expressing epithelial ovarian cancer
Sergey Karakashev · The Wistar Institute · funded by National Institutes of Health
2020–2025 · research · R01
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2020–2025 · research · R01
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2023 · research · R01
Regulation of tumor recurrence by stress activated neutrophils
Rugang Zhang · The Wistar Institute · funded by National Institutes of Health
2020–2023 · research · R01
Molecular Mechanism of UV Protection in Cutaneous Melanoma
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · Global Health
Wistar Institute of Anatomy & Biology - to evaluate mucosal antibodies against mucosal pathogens
The Wistar Institute · funded by Bill and Melinda Gates Foundation
2020–2023 · research · R01
Molecular Mechanism of UV Protection in Cutaneous Melanoma
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2021 · research · R21
Targeting the host NDP kinase to abrogate viral dissemination
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2025 · research · R01
Regulation of neonatal inflammation by myeloid-derived suppressor cells
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2020–2023 · research · R01
Molecular Mechanism of UV Protection in Cutaneous Melanoma
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2022 · career development · K99
Targeting HSP70 in CARM1-expressing epithelial ovarian cancer
Sergey Karakashev · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
Regulation of neonatal inflammation by myeloid-derived suppressor cells
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2020–2027 · research · R37
Investigating p16 Loss in Pro-tumorigenic Metabolism
Katherine Marie Aird · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Impact of Sex on Glycosylation-dependent Antibody-mediated Innate Immune Functions During HIV Infection
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2019–2025 · research · Global Health
Wistar Institute of Anatomy & Biology - to evaluate a novel single shot platform for controlling disease in HIV infected individuals
The Wistar Institute · funded by Bill and Melinda Gates Foundation
2019–2023 · research · R01
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
David B. Weiner · The Wistar Institute · funded by National Institutes of Health
2019–2022 · grant · OCRP
Characterization of Novel Vaccine Targeting Follicle-Stimulating Hormone Receptor in Ovarian Cancer
David Weiner · The Wistar Institute · funded by Congressionally Directed Medical Research Programs
2019–2024 · research · R01
Effects of Mu-opiate receptor engagement on the persistence of HIV-associated activation and viral reservoirs in individuals receiving medication assisted treatment for opioid use disorder
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
The impact of coding region variants on mutant p53 biology
Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Understanding PPARgamma signaling in melanoma brain metastasis
Qing Chen · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Sialic Acid Modulation of HIV-associated Chronic Inflammaging
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Effects of Mu-opiate receptor engagement on the persistence of HIV-associated activation and viral reservoirs in individuals receiving medication assisted treatment for opioid use disorder
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
David S Metzger · The Wistar Institute · funded by National Institutes of Health
2019–2023 · research · R01
Role of an Integrator-EGR axis in the regulation of myeloid enhancers
Alessandro Gardini · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Synthetic lethality based combination approaches to ARID1A mutation in ovarian cancer
Rugang Zhang · The Wistar Institute · funded by National Institutes of Health
2019–2024 · grant · DP2
The multifaceted role of acetate in cancer
Zachary T Schug · The Wistar Institute · funded by National Institutes of Health
2019–2020 · research · R01
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
Edna Cukierman · The Wistar Institute · funded by National Institutes of Health
2019–2023 · research · R01
Role of an Integrator-EGR axis in the regulation of myeloid enhancers
Alessandro Gardini · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Sialic Acid Modulation of HIV-associated Chronic Inflammaging
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Synthetic lethality based combination approaches to ARID1A mutation in ovarian cancer
Rugang Zhang · The Wistar Institute · funded by National Institutes of Health
2019–2022 · grant · PRCRP
Regulation of Myeloma Progression by Protein Citrullination
Yulia Nefedova · The Wistar Institute · funded by Congressionally Directed Medical Research Programs
2019–2023 · research · R01
Stress Response Functions of ADAR1 Regulated by MAP Kinases
Kazuko Nishikura · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Role of an Integrator-EGR axis in the regulation of myeloid enhancers
Alessandro Gardini · The Wistar Institute · funded by National Institutes of Health
2019–2024 · research · R01
Understanding PPARgamma signaling in melanoma brain metastasis
Qing Chen · The Wistar Institute · funded by National Institutes of Health